AIM: To evaluate the association between xeroderma pigmentosum group D (XPD), genetic polymorphism Lys751Gln and esophageal cancer risk. METHODS: We searched PubMed up to September 1, 2010 to identify eligible studies. A total of 10 case-control studies including 2288 cases and 4096 controls were included in the meta-analysis. Statistical analysis was performed with Review Manage version 4.2. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. RESULTS: The results suggested that there is no significant association between XPD Lys751Gln polymorphism and esophageal cancer susceptibility in the overall population. However, in subgroup analysis by histology type, a significant association was found between XPD Lys751Gln polymorphism and esophageal adenocarcinoma (for CC vs AA: OR = 1.25, 95% CI = 1.01-1.55, P = 0.05 for heterogeneity). CONCLUSION: Our meta-analysis suggested that XPD Lys751Gln polymorphism may be associated with increased risk of esophageal adenocarcinoma.
AIM: To evaluate the association between xeroderma pigmentosum group D (XPD), genetic polymorphism Lys751Gln and esophageal cancer risk. METHODS: We searched PubMed up to September 1, 2010 to identify eligible studies. A total of 10 case-control studies including 2288 cases and 4096 controls were included in the meta-analysis. Statistical analysis was performed with Review Manage version 4.2. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. RESULTS: The results suggested that there is no significant association between XPD Lys751Gln polymorphism and esophageal cancer susceptibility in the overall population. However, in subgroup analysis by histology type, a significant association was found between XPD Lys751Gln polymorphism and esophageal adenocarcinoma (for CC vs AA: OR = 1.25, 95% CI = 1.01-1.55, P = 0.05 for heterogeneity). CONCLUSION: Our meta-analysis suggested that XPD Lys751Gln polymorphism may be associated with increased risk of esophageal adenocarcinoma.
Entities:
Keywords:
Esophageal cancer; Mwta-analysis; Polymorphism; Xeroderma pigmentosum group D
Authors: Geoffrey Liu; Wei Zhou; Beow Y Yeap; Li Su; John C Wain; John M Poneros; Norman S Nishioka; Thomas J Lynch; David C Christiani Journal: Carcinogenesis Date: 2007-01-29 Impact factor: 4.944
Authors: S T Mayne; H A Risch; R Dubrow; W H Chow; M D Gammon; T L Vaughan; D C Farrow; J B Schoenberg; J L Stanford; H Ahsan; A B West; H Rotterdam; W J Blot; J F Fraumeni Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-10 Impact factor: 4.254
Authors: Alan G Casson; Zuoyu Zheng; Susan C Evans; Paul J Veugelers; Geoffrey A Porter; Duane L Guernsey Journal: Carcinogenesis Date: 2005-05-05 Impact factor: 4.944
Authors: James Doecke; Zhen Zhen Zhao; Nirmala Pandeya; Shahram Sadeghi; Mitchell Stark; Adèle C Green; Nicholas K Hayward; Penelope M Webb; David C Whiteman Journal: Int J Cancer Date: 2008-07-01 Impact factor: 7.396
Authors: Jennifer J Hu; M Craig Hall; Lawrence Grossman; Mohammad Hedayati; David L McCullough; Kurt Lohman; L Douglas Case Journal: Cancer Res Date: 2004-02-01 Impact factor: 12.701